Products & ReviewLife Sciences

OsteoMAX-XF™ Differentiation Medium

EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols. The u…

Merck

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Average Rating 5.0

|1Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Sure it was very good result

 

Average Rating 5.0

Application Area:

Food safety study

It is an excellent product so keep it up.

Review Date: 18 Oct 2021 | Merck

EMD Millipore’s OsteoMAX-XF™ Differentiation Medium is specially formulated to readily differentiate human mesenchymal stem cells into the osteogenic lineage as assessed by alizarin red and alkaline phosphatase staining. This proprietary formulation was developed using Plasticell’s CombiCultTM, a patented, bead-based, combinatorial technology specially developed for discovery of novel stem cell differentiation protocols. The unique characteristics of OsteoMAX-XF™ Differentiation Medium include: 1) Serum-free, xeno-free, defined medium formulation and 2) Rapid, robust, and highly efficient mineralization and bone nodule formation in standard tissue culture system by as early as 7 days of differentiation.

Using EMD Millipore's OsteoMAX-XF™ Differentiation Media, we typically obtain >80% mature osteocytes from bone marrow derived mesenchymal stem cells. Efficiency of osteogenic differentiation may vary, depending upon the source and quality of the mesenchymal stem cells and if variations to the protocol are introduced.

Product Overview

Links